Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer

67Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

c-Raf is an essential component of the extracellular related kinase (ERK) signal transduction pathway. Immunohistochemical staining indicated that c-Raf was present in 49/53 ovarian adenocarcinomas investigated and high c-Raf expression correlated significantly with poor survival (P = 0.002). c-Raf protein was detected in 15 ovarian cancer cell lines. Antisense oligodeoxynucleotides (ODNs) (ISIS 5132 and ISIS 13650) reduced c-Raf protein levels and inhibited cell proliferation in vitro. Selectivity was demonstrated by the lack of effect of ISIS 5132 on A-Raf or ERK, while a random ODN produced only minor effects on growth and did not influence c-Raf expression. ISIS 5132 produced enhanced apoptosis and cells accumulated in S and G2/M phases of the cell cycle. In vivo, ISIS 5132 inhibited growth of the s.c. SKOV-3 xenograft while a mismatch ODN had no effect. These data indicate that high levels of c-Raf expression may be important in ovarian cancer and use of antisense ODNs targeted to c-Raf could provide a strategy for the treatment of this disease. © 2001 Cancer Research Campaign.

Cite

CITATION STYLE

APA

McPhillips, F., Mullen, P., Monia, B. P., Ritchie, A. A., Dorr, F. A., Smyth, J. F., & Langdon, S. P. (2001). Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer. British Journal of Cancer, 85(11), 1753–1758. https://doi.org/10.1054/bjoc.2001.2139

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free